Imaging response predictors following drug eluting beads chemoembolization in the neoadjuvant liver transplant treatment of hepatocellular carcinoma

Table 6 Characteristics of lesion according to percentage of necrosis - hepatocellular carcinoma treated

Variable	Description	P value
HCC diameter (cm)1	0.21	< 0.001
Chemoembolic dose (mg)1	0.31	< 0.001
Feeding vessel1	0.093	0.11
Liver segment2		0.7093
1	41.7 ± 49.2
2	60.9 ± 43.6
3	64 ± 38.9
4	53 ± 42.4
5	47.3 ± 42
6	50 ± 43.6
7	56.2 ± 41.3
8	59.3 ± 43.2
Pseudocapsule		< 0.0014
No	39.2 ± 43.8
Yes	63.4 ± 39.2
Selective catheterization5		0.0383
Proximal	70.4 ± 43.9
Segmental	46.3 ± 41.6
Subsegmental	59.1 ± 41.9
Hypervascular6		0.9883
No	54.4 ± 43.6
Yes	54.3 ± 42.2
End point7		0.1983
No	66.1 ± 37.7
Yes	54.2 ± 42.6

¹Pearson's correlation;

²Liver segmentation according to Couinaud;

³ANOVA;

⁴Student t-test;

⁵Selective catheterization levels for hepatic chemoembolization (Proximal: right/left hepatic artery trunk; Segmental: right/left hepatic artery segmental branch; Subsegmental: right/left hepatic artery subsegmental branch);

⁶Hepatocellular carcinoma identified as hypervascular during hepatic angiography;

⁷Hepatocellular carcinoma that obtained vascular stasis during the first chemoembolization session. Data expressed as mean ± SD. HCC: Hepatocellular carcinoma.